5 nov 2019
CPhI Worldwide 2019
Taiwan Pharmaceutical Alliance

Taiwan Pharmaceutical Alliance

Exhibitor at CPhI Worldwide 2019 stand 80B50, Integrated Pharma

About us

Taiwan Pharmaceutical Alliance (TPA)  comprises several Taiwan-based API and FDF generic manufacturers.  It's established with the goal of integrating the strength of Taiwan industry and providing one-stop services for oversea partners.  Some niche products of TPA include MDI/ DPI, liposome & microsphere injectables, high-potent soft gel, OROS tablets, eye drops and biosimilar etc.  TPA could also provide CDMO/ CMO, license in/out, and trading services.  Taiwan is a PIC/S and ICH member.  All TPA facilities pass PIC/S GMP and some of them are USFDA, EU, and/or Japan PMDA GMP inspected.  TPA is your trustworthy partner in the dynamic markets.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Custom Manufacturing of Dosage Form Drugs More

Products featured at CPhI Worldwide 2019

Taiwan Pharmaceutical Alliance

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 80B50